Sangamo BioSciences Announces Publication of Data From Program to Develop a ZFP Therapeutic® for Parkinson's Disease
Dec. 13, 2010 /PRNewswire
http://www.prnewswire.com/news-relea...111776389.html
Produce GDNF
"We are enthusiastic about the success of this novel ZFP Therapeutic approach to date and hopeful that its further development can take us closer to our goal of delivering Parkinson's patients better treatment options," said Todd Sherer, Ph.D., Chief Program Officer at MJFF.